Merck’s Price Target, Estimates Raised at Barclays Capital (MRK)
February 9th, 2010

Drugmaker Merck & Co., Inc. (MRK) saw its price target and earnings estimates raised on Tuesday by analysts at Barclays Capital, ahead of its fourth quarter earnings report.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!



Stock Screener
RSS

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the